A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin-Reference-Cited by-同舟云学术

A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin

Published:2020-04-08 Issue:1 Volume:112 Page:1-7
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Aleidan Fahad A. S.,Aljarba Ghada A.,Aldakhil Alaa A.,Allehyani Batol I.,Yahia Madona A.,Alghtani Nuorah E.,Badri Motasem,Alaklabi Ali A.,Alsuhaibani Ahmad,Crowther Mark A.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-020-02873-2.pdf

Reference22 articles.

1. Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. Lancet. 2010;375(9713):500–12. https://doi.org/10.1016/S0140-6736(09)60996-X.

2. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy The eighth ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2008;133:844S–86S. https://doi.org/10.1378/chest.08-0761.

3. Safety of levenox in pregnancy. ACOG committee Opinion No. 276. American college of obstetricians and gynaecologists. Obstet Gynecol. 2002;100:845–6.

4. Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol. 1999;181:1113–7. https://doi.org/10.1016/S0002-9378(99)70091-8.

5. Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol. 2004;191:1024–9. https://doi.org/10.1016/j.ajog.2004.05.050.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels;Frontiers in Pharmacology;2024-07-12

2. How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?;Clinical and Applied Thrombosis/Hemostasis;2022-01

3. Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review;Seminars in Thrombosis and Hemostasis;2021-06-15

4. Low-molecular-weight heparin for prevention of unexplained recurrent miscarriage;European Journal of Obstetrics & Gynecology and Reproductive Biology;2021-05

5. Prophylactic Anticoagulation With Intermediate-Dose Certoparin in Vascular-Risk Pregnancies—The PACER-VARP Registry;Clinical and Applied Thrombosis/Hemostasis;2021-01-01